Pontifical Xavierian University

NYU Langone Hospital--Long Island Appoints Mario E. Lacouture, MD, as the New Chief of Dermatology

Retrieved on: 
Friday, December 1, 2023
Senior, Patient, Research, Textbook, Guideline committee VDI 2343, NYU, CHANCE, Quality of life, Multimedia, Science, Society, Professor, NYU Langone Health, Northwestern University, Weill Cornell Medicine, Cleveland Clinic, General surgery, University, Survivor, Antibody, Skin, Cone Health Women's Hospital, Medical director, Pontifical Xavierian University, Breast cancer, MD, Wastewater treatment, EGFR, MSKCC, Hospital, Pharmaceutical industry, Medical imaging, Nursing, Boston, Cancer, Immunology, Brigham, Dermatology, Medicine, New York (magazine)

MINEOLA, N.Y., Dec. 1, 2023 /PRNewswire/ -- Following a national search, NYU Langone Health is pleased to announce that Mario E. Lacouture, MD, has been named the new Chief of the Dermatology Division, Department of Medicine, Long Island.

Key Points: 
  • MINEOLA, N.Y., Dec. 1, 2023 /PRNewswire/ -- Following a national search, NYU Langone Health is pleased to announce that Mario E. Lacouture, MD, has been named the new Chief of the Dermatology Division, Department of Medicine, Long Island.
  • "The opportunity to lead NYU Langone Dermatology on Long Island aligns with my commitment to high-quality, accessible care and my fondness for the people of the Island," said Dr. Lacouture.
  • Before joining NYU Langone Health, Dr. Lacouture was an Attending Physician and Program Director of Oncodermatology and Research in the Dermatology Service at Memorial Sloan Kettering Cancer Center (MSKCC) in Manhattan.
  • He was also a Professor in the Department of Dermatology at Weill Cornell Medicine in New York.

Ecopetrol informs appointments in senior management and legal representation

Retrieved on: 
Monday, October 2, 2023
Plata, Permian, Social responsibility, Pontifical Xavierian University, Faculty, Sustainability, Corporate Affairs, Specialization, Drinking water, CESA, Socioeconomics, Telecommunications, Columbia University, Communication, Policy, Universidad Externado de Colombia, Risk management, Museo del Prado, Enterprise, XM, Individual, Ombudsman's Office of Colombia, Charles III University of Madrid, Acquisition, Sanitation, Gulf of Mexico, Ombudsman, Corporate finance, ISA, BVC, Judiciary, Growth, Environment, Ecopetrol, Transport, Fraud, Aldemar Reyes, Sustainable development, EC, NYSE, Corruption, Behavior, Law, Management, Corporation

He has over thirty years of experience in the legal advisory profession and in managerial and strategic public positions in oil & gas, telecommunications, drinking water, and sanitation companies.

Key Points: 
  • He has over thirty years of experience in the legal advisory profession and in managerial and strategic public positions in oil & gas, telecommunications, drinking water, and sanitation companies.
  • From 2017 until assuming this vice presidency, he was Manager of Legal Management in the Legal Vice Presidency of Ecopetrol S.A.
    Sandra Lucía Rodríguez Rojas as Vice President of Sustainable Development effective from October 20, 2023.
  • Luis Carlos Plata Prince, Attorney of the Judicial and Extrajudicial Management, as the alternate legal representative for judicial and extrajudicial matters.
  • Aldemar Alfonso Mejía Prado, Planning and Procurement Manager, as the alternate legal representative for the procurement of goods and services.

HarbourVest Partners Appoints Javier Rodriguez as a Managing Director

Retrieved on: 
Thursday, May 11, 2023
Asset Management, Professional Services, Finance, HarbourVest Partners, Investment Advisers Act of 1940, University, Engineering, Chartered Institute of Public Finance and Accountancy, Head, MBA, Treasury, Goldman Sachs, Philosophy, Pontifical Xavierian University, Analytics, Performance measurement, Imperial College London, Donor managed investment account, Performance, Accounting, Automation, Financial adviser, Science

HarbourVest Partners, the global private markets investment specialist, today announced the appointment of Javier Rodriguez as a managing director and Head of Client Operations.

Key Points: 
  • HarbourVest Partners, the global private markets investment specialist, today announced the appointment of Javier Rodriguez as a managing director and Head of Client Operations.
  • In this newly created role, Rodriguez will oversee the cross-functional integration of the Firm’s Client Experience, Investment Accounting, Treasury, Portfolio Analytics, and Performance Measurement teams.
  • “We are excited to welcome Javier to HarbourVest,” said John Toomey, Managing Director at HarbourVest Partners.
  • Most recently he was a Managing Director, and head of RIA Custody Operations and Client Experience.

The National Kidney Foundation Honors Dr. Ana Ricardo with Distinguished Service Award

Retrieved on: 
Wednesday, April 12, 2023
Volunteering, University, Diet, Chronic kidney disease, Diabetes, Education, Kidney disease, Health, Nephrology, Research fellow, Michael Reese Hospital, Sleep, Research, UIC, Risk, Pontifical Xavierian University, Transplant, Hypertension, Public health, MD, Patient, NKF, Medical Center, Internal medicine, University of Illinois Urbana-Champaign, National Kidney Foundation, Conditional sentence, Diabetic nephropathy, Smoking, CKD, Nursing, Pharmaceutical industry, Dietary supplement, Science, Epidemiology

NEW YORK, April 12, 2023 /PRNewswire/ -- University of Illinois at Chicago (UIC) nephrologist Ana Ricardo, MD, will receive the National Kidney Foundation (NKF) Medical Advisory Board Distinguished Service Award, which recognizes individuals for their educational activities and community service in promoting the mission of NKF on a local level.

Key Points: 
  • NEW YORK, April 12, 2023 /PRNewswire/ -- University of Illinois at Chicago (UIC) nephrologist Ana Ricardo, MD, will receive the National Kidney Foundation (NKF) Medical Advisory Board Distinguished Service Award, which recognizes individuals for their educational activities and community service in promoting the mission of NKF on a local level.
  • Further, her research is focused on health disparities and health behaviors in chronic kidney disease (CKD).
  • Dr. Ricardo is also a committed volunteer for the KidneyMobile® screening program, which screens for kidney disease and risk factors including diabetes and hypertension.
  • "We need to spread the word that a great proportion of kidney disease is preventable," Dr. Ricardo said.

Board of Directors of Ecopetrol S.A. appoints new Chairman of Ecopetrol S.A.

Retrieved on: 
Wednesday, April 12, 2023
Permian, Telecommunications, Compensation, Multimedia, Culture Committee of the Parliament of Georgia, Pontifical Xavierian University, Manager, XM, National university, Acquisition, Gulf of Mexico, Engineering, ISA, Headhunting, BVC, Growth, Policy, Ecopetrol, Transport, EC, TGI, NYSE, Behavior, Nomination, Management

BOGOTA, Colombia, April 12, 2023 /PRNewswire/ -- Ecopetrol S.A. (BVC: ECOPETROL; NYSE: EC) informs that its Board of Directors, in session on April 11th 2023, appointed Ricardo Roa Barragán as CEO of Ecopetrol S.A., who will take office no later than April 30th 2023.

Key Points: 
  • BOGOTA, Colombia, April 12, 2023 /PRNewswire/ -- Ecopetrol S.A. (BVC: ECOPETROL; NYSE: EC) informs that its Board of Directors, in session on April 11th 2023, appointed Ricardo Roa Barragán as CEO of Ecopetrol S.A., who will take office no later than April 30th 2023.
  • The appointment took place after a rigorous analysis of the proposed candidates, in accordance with the Ecopetrol S.A. Chairman's Succession Policy and other applicable regulations.
  • The process of selecting and appointing the new president took place in several stages.
  • Ecopetrol is the largest company in Colombia and one of the main integrated energy companies in the American continent, with more than 18,000 employees.

Torrance Dentist Dr. Adriana Barrera of Barrera Advanced Dentistry is Selected as a 2023 Top Patient Rated Dentist by Find Local Doctors

Retrieved on: 
Monday, April 3, 2023
Linda, American Dental Association, Madison Street, Doctor, UCLA School of Dentistry, Dental implant, Loma Linda University, California Dental Association, Suite, Dentist, Trust, Patient, Physician, Prosthodontics, Pontifical Xavierian University, Dentistry

TORRANCE , Calif., April 3, 2023 /PRNewswire-PRWeb/ -- As a result of the superior ratings and exceptional online reviews the clinic has received from satisfied patients, Find Local Doctors has recognized Dr. Adriana Barrera and her team at Barrera Advanced Dentistry in Torrance, California, with this prestigious award. This well-respected clinic is among the premier group of dental practices to earn this designation. Find Local Doctors is a trusted online directory that helps consumers easily locate qualified physicians and dentists in their area. Dr. Adriana Barrera has been treating patients for over 20 years, delivering advanced, comprehensive dentistry to countless patients and families. With her extensive training and clinical experience, she is proud to offer the most advanced dental treatments and procedures spanning all facets of preventive, restorative and cosmetic dentistry. Dr. Barrera and her dental staff are passionate about helping patients smile, by meeting dental goals through the clinic's many services such as routine cleanings, gum disease treatments, dental implants, oral surgery and more. Barrera Advanced Dentistry welcomes patients to an inviting and friendly atmosphere that focuses on modern dentistry that is comfortable, safe and affordable.

Key Points: 
  • TORRANCE , Calif., April 3, 2023 /PRNewswire-PRWeb/ -- As a result of the superior ratings and exceptional online reviews the clinic has received from satisfied patients, Find Local Doctors has recognized Dr. Adriana Barrera and her team at Barrera Advanced Dentistry in Torrance , California, with this prestigious award.
  • Find Local Doctors is a trusted online directory that helps consumers easily locate qualified physicians and dentists in their area.
  • Dr. Adriana Barrera has been treating patients for over 20 years, delivering advanced, comprehensive dentistry to countless patients and families.
  • Barrera Advanced Dentistry welcomes patients to an inviting and friendly atmosphere that focuses on modern dentistry that is comfortable, safe and affordable.

Amid International Expansion, Omnicon Again Named Among Winners of Deloitte's Best Managed Companies in Colombia (MEC) Program

Retrieved on: 
Thursday, January 12, 2023
Pontifical Xavierian University, Face, Olaf, Running, Automation, MEC, Food, Risk management, List of Transformers: Energon characters

CALI, Colombia, Jan. 12, 2023 /PRNewswire-PRWeb/ -- Omnicon, a global industry-leading system integrator of industrial automation, smart manufacturing, consulting, and data managements, today announced the company is again a recipient of Deloitte's Best Managed Companies award which weighs several factors to bring attention to high-achieving medium-sized private companies. Omnicon is recognized as a Best Colombian Company for 2022 and was previously recognized in 2021.

Key Points: 
  • Deloitte, Banco de Bogotá and the Pontificia Universidad Javeriana announce Omnicon as a repeat recipient of the second edition of the Best Colombian Companies (MEC) program.
  • Omnicon is recognized as a Best Colombian Company for 2022 and was previously recognized in 2021.
  • The Colombian Best Managed Companies (MEC) project is a branch of the global Best Managed Companies program and aims to recognize the operational excellence of private companies around the globe.
  • Juan Carlos Olave, Client and Industry Lead Partner at Deloitte Spanish Latin America, speaks highly of Omnicon and the other recipients of the Best Managed Companies award.

Verge Genomics Appoints Diego Cadavid, M.D., as Chief Medical Officer

Retrieved on: 
Tuesday, December 6, 2022
Biotechnology, Technology, Other Health, Health, Pharmaceutical, Health Technology, Other Science, Research, Artificial Intelligence, Science, Clinical Trials, Therapy, Publication, Probability, Armed Forces Institute of Pathology, Fulcrum, Armed Forces Institute of Regenerative Medicine, Central nervous system, Amyotrophic lateral sclerosis, Drug discovery, Neuropathology, Pontifical Xavierian University, Biogen, MS, Genomics, University, Microbiology, Neurology, ALS, Drug development, Verge, Medicine, Facioscapulohumeral muscular dystrophy, SVP, AI, FSHD, Artificial intelligence, Thought, Losmapimod, Multiple sclerosis, UTHSCSA, Georgetown University, Pharmaceutical industry, PIKFYVE, Pathology

Verge Genomics, a clinical-stage, tech-enabled biotechnology company pioneering the use of artificial intelligence (AI) and human data to transform drug discovery, announced today that it appointed Diego Cadavid, M.D., as its first Chief Medical Officer.

Key Points: 
  • Verge Genomics, a clinical-stage, tech-enabled biotechnology company pioneering the use of artificial intelligence (AI) and human data to transform drug discovery, announced today that it appointed Diego Cadavid, M.D., as its first Chief Medical Officer.
  • Before joining Verge, Dr. Cadavid served as Chief Medical Officer of X4 Pharmaceuticals where he led the clinical development of mavorixafor and recently delivered positive phase 3 data.
  • His work included the rapid advance of losmapimod from target identification to proof of concept in Facioscapulohumeral Muscular Dystrophy (FSHD).
  • What stands out to me most, though, is his knack using disruptive innovation to enable disciplined execution, said Alice Zhang, CEO and co-founder of Verge Genomics.

DatChat Introduces SmarterVerse, Inc. C-Suite Team

Retrieved on: 
Monday, August 1, 2022
Metaverse, Customer experience, University, Specialization, Ingrith Johnson Deyrup-Olsen, GLOBE, Universidad, Salazar, CEO, Social media, SEC, History, Binary relation, Guinness World Records, Risk, Control, Solution, Digital twin, Ownership, Marketing, German Developer Innovation Prize, Social, Financial management, Pontifical Xavierian University, Adoption, Leadership, Technology, Company, Accenture, University of Barcelona, B2B, Life, Increase, Digital architecture, Social network, Google, LATAM, Mobile phone, Management, Blockchain

NEW BRUNSWICK, N.J., Aug. 01, 2022 (GLOBE NEWSWIRE) -- DatChat, Inc. ("DatChat" or the "Company") (Nasdaq: DATS), a secure messaging, metaverse and social media company, today introduced its SmarterVerse, Inc. c-suite team who will develop The Habytat, a recently announced mobile-based social networking metaverse.

Key Points: 
  • NEW BRUNSWICK, N.J., Aug. 01, 2022 (GLOBE NEWSWIRE) -- DatChat, Inc. ("DatChat" or the "Company") (Nasdaq: DATS), a secure messaging, metaverse and social media company, today introduced its SmarterVerse, Inc. c-suite team who will develop The Habytat, a recently announced mobile-based social networking metaverse.
  • SmarterVerse, Inc., a wholly owned DatChat subsidiary, entered a joint venture with MetaBizz to develop The Habytat.
  • The Habytat will democratize ownership in the metaverse by making land obtainable for almost anyone.
  • DatChat Inc. is a secure messaging, metaverse and social media Company.

SpringWorks Therapeutics Appoints Carlos Albán to its Board of Directors

Retrieved on: 
Friday, July 15, 2022
Retirement, Leadership, Research, Economics, International Pharmaceutical Students' Federation, Cancer, Patient, LinkedIn, Regulation of tobacco by the U.S. Food and Drug Administration, Solution, Nasdaq, GLOBE, Private Securities Litigation Reform Act, Food, Twitter, Hematological Cancer Research Investment and Education Act, General manager, Goal, AbbVie, GSK, European Operations Management Association, Commercial Operating System (COS), Industry, COVID-19, Precision medicine, Vice, Degenerative disease, Therapy, Pontifical Xavierian University, FDA, Abbott Laboratories, Pharmaceutical industry, Management, Medication

STAMFORD, Conn., July 15, 2022 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today announced the appointment of Carlos Albn to the Companys Board of Directors.

Key Points: 
  • STAMFORD, Conn., July 15, 2022 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today announced the appointment of Carlos Albn to the Companys Board of Directors.
  • Carlos success in building and leading global commercial organizations will be valuable as SpringWorks continues its planned transition into a commercial-stage company in the coming year and we are thrilled to welcome him to our Board, said Saqib Islam, Chief Executive Officer of SpringWorks.
  • SpringWorks has an exciting opportunity ahead to bring first- and best-in-class medicines to patients with devastating rare diseases and cancer, said Mr. Albn.
  • Mr. Albn joins the SpringWorks Board of Directors with significant leadership and commercial experience gained during his more than 30-year career in the pharmaceutical industry.